JLB & Associates Inc. Buys 243 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

JLB & Associates Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,251 shares of the healthcare conglomerate’s stock after acquiring an additional 243 shares during the period. UnitedHealth Group comprises about 2.7% of JLB & Associates Inc.’s portfolio, making the stock its 14th largest position. JLB & Associates Inc.’s holdings in UnitedHealth Group were worth $19,510,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 1.8%

Shares of UnitedHealth Group stock opened at $307.84 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market cap of $279.25 billion, a P/E ratio of 19.86, a P/E/G ratio of 1.37 and a beta of 0.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock’s 50 day simple moving average is $381.74 and its 200-day simple moving average is $470.20.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.87%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer now directly owns 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Raymond James cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. TD Securities reissued a “hold” rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Truist Financial reiterated a “buy” rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $426.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.